SIGN UP

Christopher Viehbacher, new Biogen CEO

November 10, 2022 08:12 AM ESTUpdated 08:47 AM

Biogen selects new CEO: former Sanofi head Chris Viehbacher

Zachary Brennan

Senior Editor

Biogen’s months-long search for a new CEO landed on the choice of former Sanofi CEO Chris Viehbacher, who was previously ousted from his top spot …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

TRENDING NOW

FDA offers more guidance on developing cell and gene therapies

Rocket shares promising long-term results from rare heart disease gene therapy in small study

A rare neurological disease is Sage’s last, best hope after failures in depression

Novartis strikes radiopharma deal with Ratio worth up to $745M

Neurogene patient had life-threatening side effect in Rett syndrome study

sponsored

Are programs with compounded GLP-1s safe for your population?